Eloxx Pharmaceuticals ELOX
-
-
-
已收盤：-
淨值比明細
年季 | 收盤價 | 權益總計(百萬) | 稅後權益報酬率(%) | 稅後純益(百萬) | 稅後資產報酬率(%) | 資產總計(百萬) |
|---|---|---|---|---|---|---|
| 2026Q1 | -8 | -4 | 9 | |||
| 2025Q1 | -2 | |||||
| 2023Q4 | -23 | -3 | -74.57 | 2 | ||
| 2023Q3 | -20 | -4 | -59.69 | 6 | ||
| 2023Q2 | -19 | -4 | -65.81 | 6 | ||
| 2023Q1 | -16 | -6 | -43.99 | 7 | ||
| 2022Q4 | -11 | -6 | -26.33 | 21 | ||
| 2022Q3 | -5 | -8 | -25.1 | 27 | ||
| 2022Q2 | 2 | -157.33 | -11 | -27.74 | 33 | |
| 2022Q1 | 12 | -68.21 | -12 | -26.18 | 44 | |
| 2021Q4 | 22 | -43.66 | -12 | -24.05 | 45 | |
| 2021Q3 | 33 | -26.85 | -10 | -17.04 | 55 | |
| 2021Q2 | 41 | -166.19 | -36 | -89.06 | 61 | |
| 2021Q1 | 3 | -133.96 | -9 | -37.12 | 20 | |
| 2020Q4 | 10 | -48.42 | -6 | -20.62 | 26 | |
| 2020Q3 | 15 | -37.42 | -7 | -18.16 | 33 | |
| 2020Q2 | 20 | -33.89 | -8 | -18.14 | 40 | |
| 2020Q1 | 26 | -44.65 | -14 | -26.32 | 47 | |
| 2019Q4 | 36 | -28.57 | -12 | -18.32 | 59 | |
| 2019Q3 | 45 | -25.63 | -13 | -17.51 | 68 |